FindTrial
Sign In

Comparing the effect of two drugs (AMRITABHALLATAKA and AROGYAVARDHINI VATI) After therapeutic purgation in Psoriasis

COMPARATIVE CLINICAL STUDY TO EVALUATE THE EFFICACY OF AMRITBHALLATAKA AND AROGYAVARDHINI VATI AFTER VIRECHANA IN THE MANAGEMENT OF KITIBHA KUSHTHA (PSORIASIS)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/02/039985
Enrollment
70
Registered
2022-02-03
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L409- Psoriasis, unspecified Health Condition 2: L409- Psoriasis, unspecified

Interventions

None listed

Sponsors

All India Institute Of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient having clinical features of Kitibha Kushtha(Psoriasis) 2.Age â?? 21 - 60 yrs.,irrespective of sex, religion, occupation 3.Patients who are Snehana ,Swedana and Virechana Yogya. 4.Able and willing to give written informed consent.

Exclusion criteria

Exclusion criteria: 1.Lactating and pregnant women. 2.Patients addicted to alcohol. 3.Patients suffering from severe disease like Diabetes (uncontrolled), Renal disease, Liver disease. 4.Patients who are allergic to Bhallataka will be excluded.

Design outcomes

Primary

MeasureTime frame
Improvement in signs and symptoms of Kitibha kushtha(Psoriasis). Timepoint: 105 days—

Secondary

MeasureTime frame
Improvement in the quality of life of patients of Kitibha kushtha(Psoriasis) as assessed by Dermatology life quality index questionarre. Timepoint: 105 days—

Countries

India

Contacts

Public ContactPROF DR JONAH S

All India Institute Of Ayurveda

jonahdr@gmail.com9448262298

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026